16 studies found for:    RETINAL VASCULITIS
Show Display Options
Rank Status Study
1 Recruiting Optical Coherence Tomography (OCT) in Retinal Vasculitis
Condition: Retinal Vasculitis
Intervention:
2 Completed Biological Markers in Retinal Vasculitis
Condition: Retinal Vasculitis
Intervention:
3 Unknown  Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
Conditions: Behcet's Disease;   Panuveitis;   Posterior Uveitis;   Retinal Vasculitis
Interventions: Drug: Cyclosporin A;   Drug: Interferon-alpha2a
4 Unknown  Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
5 Completed Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease
Condition: Behcet's Syndrome
Interventions: Drug: Rituximab;   Drug: Cytotoxic Combination
6 Completed HAT in Eye Complications of Behcet's Disease
Conditions: Behcet's Syndrome;   Retinal Disease;   Uveitis
Intervention: Drug: Daclizumab
7 Terminated Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
Conditions: Retinitis;   Behcet's Syndrome
Intervention: Biological: Autologous Stem Cell Transplantation
8 Unknown  The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
Condition: Behcet's Disease
Interventions: Drug: methylorednisolone;   Other: dextrose water 5%
9 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)
10 Terminated
Has Results
Apremilast in the Treatment of Uveitis
Condition: Uveitis
Intervention: Drug: Apremilast
11 Not yet recruiting Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease
Condition: Behçet Disease
Intervention: Drug: Subcutaneous Ustekinumab
12 Not yet recruiting Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Conditions: Uveitis;   Anterior Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Scleritis;   Clinically Significant Macular Edema
Intervention: Drug: H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
13 Completed Lucentis (Ranibizumab) for Eales' Disease
Condition: Eales' Disease
Intervention: Drug: Ranibizumab
14 Recruiting Interest of Medical Imaging in the Diagnostic Strategy Vis a Vis a Suspected Horton Disease
Condition: Horton Disease
Interventions: Radiation: Vascular tomodensitometry;   Other: Magnetic resonance angiography;   Other: Vascular ultrasonography;   Other: Retinal angiography;   Other: Retinal optical coherence tomography
15 Recruiting Clinical and Molecular Investigations Into Ciliopathies
Conditions: Autosomal Recessive Polycystic Kidney Disease;   Congenital Hepatic Fibrosis;   Caroli's Disease;   Polycystic Kidney Disease;   Joubert Syndrome;   Cerebro-Oculo-Renal Syndromes;   COACH Syndrome;   Senior-Loken Syndrome;   Dekaban-Arima Syndrome;   Cogan Oculomotor Apraxia;   Nephronophthisis;   Bardet-Biedl Syndrome;   Alstrom Syndrome;   Oral-Facial-Digital Syndrome
Intervention:
16 Completed Intravitreal Infliximab in Refractory Uveitis in Behcet's Disease: A Safety and Efficacy Clinical Study
Conditions: Behçet's Disease;   Uveitis
Intervention: Drug: Intravitreal Infliximab

Indicates status has not been verified in more than two years